Concepedia

Henri Doods

HD

85

Publications

5K

Citations

37

H-Index

1983

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Mount Sinai Medical Center

Jeonbuk National University

University of Applied Sciences Biberach

Pharmazeutische Fabrik Dr. Reckeweg (Germany)

Henri Doods is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1983–2021

85

Publications

85

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

Henri Doods, Gerhard Hallermayer, Dongmei Wu et al. · British Journal of Pharmacology · 2000 · 467 citations · Full text

The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226

K Rudolf, Wolfgang Eberlein, Wolfhard Engel et al. · European Journal of Pharmacology · 1994 · 374 citations

, , +7

Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents

H. Wieland, W. Engel, Wolfgang Eberlein et al. · British Journal of Pharmacology · 1998 · 257 citations · Full text

Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired

Rémi Quirion, Amy Wilson, Wayne Rowe et al. · Journal of Neuroscience · 1995 · 205 citations · Full text

, , +19

BIIE0246: A selective and high affinity neuropeptide Y Y2 receptor antagonist

Henri Doods, Wolfram Gaida, H. Wieland et al. · European Journal of Pharmacology · 1999 · 189 citations

, , +8

Rows per page

1–5 of 85